HR unicorn Deel prepares for IPO as soon as 2026 after revenue jump

HR unicorn Deel prepares for IPO as soon as 2026 after revenue jump


Key Points
  • Human resources software startup Deel has hit an annual revenue run rate of $800 million, the company told CNBC.
  • Deel also added two major new shareholders to its capitalization table, General Catalyst and Abu Dhabi sovereign wealth fund Mubadala, as part of a $300 million secondary share sale.
  • “We are getting ready to go out, potentially next year or a bit later,” Deel CEO Alex Bouaziz told CNBC, discussing the firm’s IPO plans.



Source

Stocks making the biggest moves midday: Freeport-McMoran, Coupang, Target & more
Finance

Stocks making the biggest moves midday: Freeport-McMoran, Coupang, Target & more

Check out the companies making the biggest moves midday: Freeport-McMoRan — The miner rose 3.1% as gold and other metals scaled to record levels. Target — The retailer rose more than 1% after The Financial Times reported, citing sources, that hedge fund Toms Capital Investment Management made a big investment in Target. Pressure from the […]

Read More
Stocks making the biggest moves premarket: Nvidia, Micron, SanDisk & more
Finance

Stocks making the biggest moves premarket: Nvidia, Micron, SanDisk & more

Check out the companies making headlines before the bell. Nvidia — The semiconductor firm’s stock rose 0.5% after it agreed to pay $20 billion to acquire assets from artificial intelligence startup Groq, marking its largest purchase ever. Micron Technology , SanDisk — The digital memory firms’ stocks were up after DigiTimes reported , citing industry […]

Read More
Stocks making the biggest moves premarket: Nike, Dynavax Technologies, UiPath & more
Finance

Stocks making the biggest moves premarket: Nike, Dynavax Technologies, UiPath & more

Check out the companies making headlines before the bell: Nike — The sportswear stock rose 2% after a filing showed that Apple CEO Tim Cook bought nearly $3 million worth of Nike shares. Dynavax Technologies — The biopharmaceutical stock surged 38% after Sanofi said it will acquire Dynavax in a deal with a total equity […]

Read More